Sibutramine Hydrochloride: Meridia, Reductil

CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.

{m} Entries

Phase
Study Indication or Disease
Study Name
SB238 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescen…
THAI-03-002 AbbVie_IU_icons_outlined_v3 Obesity Phase 4 Safety and Weight Reduction of Sibutramine in the Treatment of Thai Obese and Overweight Subjects
SB118 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG A Multicenter, Double-blind, Placebo-controlled, Parallel Group Study to Examine the Longer-Term Efficacy and Safety of Meridia (S…
KD200010 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination plus Sibutramine versus Placebo in Obese Hypertensive…
SB237 AbbVie_IU_icons_outlined_v3 Bulimia CSR.ORG A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia...
KD20009 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG Randomized, Placebo-Controlled Parallel-Group Comparison Evaluating the Effect of Antihypertensive Therapy and Sibutramine on Bl…
MLAY-02-001 AbbVie_IU_icons_outlined_v3 Obesity Phase 4 Randomized Trial of Obese Non-Diabetic Malaysians using Sibutramine: A Randomized Double-Blind Placebo-Controlled Study of Sibutramine in the Management of Obese Subjects in Malaysia
MLAY-02-001 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG Randomized Trial of Obese Non-Diabetic Malaysians using Sibutramine: A Randomized Double-Blind Placebo-Controlled Study of…
THAI-03-002 AbbVie_IU_icons_outlined_v3 Obesity CSR.ORG Safety and Weight Reduction in Sibutramine Treatment of Thai Obese and Overweight Subjects…